Co-Authors
This is a "connection" page, showing publications co-authored by Alessandro Armuzzi and Gianmaria Cammarota.
Connection Strength
0.540
-
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020 08 20; 26(9):1306-1314.
Score: 0.225
-
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020 Jul; 8(7):E980-E984.
Score: 0.222
-
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease. Dig Dis. 2018; 36(3):184-193.
Score: 0.047
-
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
Score: 0.046